CN102114172A - Traditional Chinese medicine for treating hyperplasia of prostate - Google Patents

Traditional Chinese medicine for treating hyperplasia of prostate Download PDF

Info

Publication number
CN102114172A
CN102114172A CN2010106039596A CN201010603959A CN102114172A CN 102114172 A CN102114172 A CN 102114172A CN 2010106039596 A CN2010106039596 A CN 2010106039596A CN 201010603959 A CN201010603959 A CN 201010603959A CN 102114172 A CN102114172 A CN 102114172A
Authority
CN
China
Prior art keywords
chinese medicine
traditional chinese
parts
radix
prostate
Prior art date
Application number
CN2010106039596A
Other languages
Chinese (zh)
Inventor
刘新壮
Original Assignee
北京绿源求证科技发展有限责任公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 北京绿源求证科技发展有限责任公司 filed Critical 北京绿源求证科技发展有限责任公司
Priority to CN2010106039596A priority Critical patent/CN102114172A/en
Publication of CN102114172A publication Critical patent/CN102114172A/en

Links

Abstract

The invention belongs to the field of traditional Chinese medicines for treating urinary system diseases, and relates to a traditional Chinese medicine for treating hyperplasia of prostate, which has good effect and quick action. The traditional Chinese medicine is prepared from Asparagus cochinchinensis, Chinese angelica root, lucid ganoderma, dan-shen, sanchi, fringed pink, gardenia fruit and other raw materials. The traditional Chinese medicine has the effects of reinforcing body resistance, invigorating qi, promoting blood circulation, dispelling blood stasis, inducing diuresis, alleviating edema, excreting dampness, and treating stranguria; and has the advantages of remarkable effect, definite drug effect and quick action.

Description

A kind of Chinese medicine for the treatment of prostatic hyperplasia
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of urinary system.
Background technology
The present Chinese medicine aspect that is used for the treatment of male prostatic hyperplasia, the deficiency that has two aspects: the one, effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of prostatic hyperplasia patients are because of can not get the treatment of active drug for a long time, frequent frequent micturition, urgent micturition, dysurea, unable, the urine retention of urine, urinary incontinence, protracted course of disease, symptoms such as very misery, and Chang Bingfa urine retention, hematuria, perineal position pain.Patient and family members thereof are very dissatisfied.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of prostatic hyperplasia, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, and the slower problem that takes effect is effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of prostatic hyperplasia adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Asparagi 5---18 parts of 15 parts of Radix Angelicae Sinensis 6---18 portions of Ganodermas 6---
Radix Salviae Miltiorrhizae 6---15 parts of 18 portions of Radix Notoginseng 3---9 portions of Herba Dianthis 5---
Fructus Gardeniae 5---15 parts
The Chinese medicine of this treatment prostatic hyperplasia is made by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is as follows: Ganoderma is broken into graininess, cross 40 mesh sieves →, concentrate → mixed, leave standstill 10-12 hours, centrifugal → as to add 75% ethanol with 95% ethanol of 3 times of volumes with hot water (95 ℃) lixiviate of 1:20 → lixiviating solution decompression, precipitate polysaccharide → dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Radix Asparagi, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Herba Dianthi, Fructus Gardeniae are extracted through conventional water extraction process, make extract extractum fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, make Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Angelicae Sinensis the body resistance strengthening and constitution consolidating in the side, benefiting QI and nourishing blood, enhancing human body immunity power; Radix Salviae Miltiorrhizae, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic; It is nourshing Yin and drynsessmoistening prescription to be aided with Radix Asparagi, removing heat-phlegm; Herba Dianthi, Fructus Gardeniae inducing diuresis for treating stranguria syndrome, Herba Dianthi clearing heat and freeing strangury removing heat from blood, the diuresis of Fructus Gardeniae heat clearing and blood cooling, the two 5 be a usefulness mutually, effect that heat clearing and blood cooling is treating stranguria enhancing is used for the treatment of urinary obstruction, the odynuria effect is distinguished.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema, the merit that eliminating dampness by diuresis is treating stranguria, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Radix Asparagi 50 gram Radix Angelicae Sinensis 70 kairine sesames 70 grams
Radix Salviae Miltiorrhizae 70 gram Radix Notoginseng 30 gram Herba Dianthis 50 grams
Fructus Gardeniae 50 grams
Weight is extracted Ganoderma with decoction and alcohol sedimentation technique in accordance with regulations; With conventional water extraction process Radix Asparagi, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Herba Dianthi, Fructus Gardeniae are extracted, make extract fine powder 72 grams altogether, Radix Notoginseng is ground into fine powder, mix with said extracted thing fine powder, stir, make fine particle, the capsule of packing into No. 0, make 364 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Radix Asparagi 100 gram Radix Angelicae Sinensis 120 kairine sesames 120 grams
Radix Salviae Miltiorrhizae 120 gram Radix Notoginseng 50 gram Herba Dianthis 100 grams
Fructus Gardeniae 100 grams
By above-mentioned same method, make 650 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Radix Asparagi 150 gram Radix Angelicae Sinensis 180 kairine sesames 180 grams
Radix Salviae Miltiorrhizae 180 gram Radix Notoginseng 80 gram Herba Dianthis 150 grams
Fructus Gardeniae 150 grams
By above-mentioned same method, make 992 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
7 parts of 7 portions of Ganodermas of 6 parts of Radix Angelicae Sinensis of Radix Asparagi
6 parts of 3 portions of Herba Dianthis of 7 portions of Radix Notoginseng of Radix Salviae Miltiorrhizae
6 parts of Fructus Gardeniaes
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
16 parts of 16 portions of Ganodermas of 12 parts of Radix Angelicae Sinensis of Radix Asparagi
12 parts of 7 portions of Herba Dianthis of 16 portions of Radix Notoginseng of Radix Salviae Miltiorrhizae
12 parts of Fructus Gardeniaes
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is example with the prostatic hyperplasia, through 7 routine clinical observations.Selecting the tcm diagnosis prostatic hyperplasia is standard: male's limb is soft weak, physical weakness, and it is not smooth to urinate---and frequent micturition, urgent micturition, dysurea, urine are unable, urine retention, urine are hesitated, urine retention; Clinical rectal touch can contact the prostate of increase.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, be the male all, there is not other serious disease, the age is 49 years old-81 years old, 71.2 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are obviously alleviated; Urine retention, urine are hesitated, urine retention obviously alleviates; The visible prostate of rectal touch increases (expansion of prostate both sides page or leaf) and alleviates.
2, effective: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are alleviated to some extent; Urine is hesitated, urine retention alleviates to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 4 people, effective 2 people, invalid 1 people, total effective rate 85.7%.

Claims (1)

1. Chinese medicine for the treatment of prostatic hyperplasia, it is characterized in that: it is to make with the component of following weight ratio: Radix Asparagi 5---15 parts, Radix Angelicae Sinensis 6---18 parts, Ganoderma 6---18 parts, Radix Salviae Miltiorrhizae 6---18 parts, Radix Notoginseng 3---9 parts, Herba Dianthi 5---15 parts, Fructus Gardeniae 5---15 parts.
CN2010106039596A 2010-12-24 2010-12-24 Traditional Chinese medicine for treating hyperplasia of prostate CN102114172A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010106039596A CN102114172A (en) 2010-12-24 2010-12-24 Traditional Chinese medicine for treating hyperplasia of prostate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010106039596A CN102114172A (en) 2010-12-24 2010-12-24 Traditional Chinese medicine for treating hyperplasia of prostate

Publications (1)

Publication Number Publication Date
CN102114172A true CN102114172A (en) 2011-07-06

Family

ID=44213172

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010106039596A CN102114172A (en) 2010-12-24 2010-12-24 Traditional Chinese medicine for treating hyperplasia of prostate

Country Status (1)

Country Link
CN (1) CN102114172A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102327350A (en) * 2011-10-10 2012-01-25 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating prostatic hyperplasia
CN102389522A (en) * 2011-09-27 2012-03-28 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating prostatic hyperplasia
CN102389477A (en) * 2011-08-14 2012-03-28 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating benign prostatic hyperplasia
CN102389523A (en) * 2011-07-23 2012-03-28 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating benign prostatic hyperplasia
CN102631442A (en) * 2012-03-31 2012-08-15 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine (TCM) for treating prostatic hyperplasia

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101843699A (en) * 2009-10-16 2010-09-29 北京绿源求证科技发展有限责任公司 Chinese medicament for treating benign prostatic hyperplasiabrain

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101843699A (en) * 2009-10-16 2010-09-29 北京绿源求证科技发展有限责任公司 Chinese medicament for treating benign prostatic hyperplasiabrain

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王邦才: "《前列腺增生症中医药治疗进展》", 《中医药临床杂志》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102389523A (en) * 2011-07-23 2012-03-28 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating benign prostatic hyperplasia
CN102389477A (en) * 2011-08-14 2012-03-28 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating benign prostatic hyperplasia
CN102389522A (en) * 2011-09-27 2012-03-28 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating prostatic hyperplasia
CN102327350A (en) * 2011-10-10 2012-01-25 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating prostatic hyperplasia
CN102631442A (en) * 2012-03-31 2012-08-15 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine (TCM) for treating prostatic hyperplasia

Similar Documents

Publication Publication Date Title
CN102772745B (en) Chinese medicinal preparation for treating cancer and preparation method thereof
CN100460008C (en) Chinese medicine composition for treating cancer
CN101670071A (en) Traditional Chinese medicine preparation for treating cancer and preparation method thereof
CN101843773B (en) Chinese medicament for treating liver cirrhosis
CN101843699B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN103055130A (en) Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method thereof
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101596230B (en) Medicinal composition for treating hepatopathy
CN102697830A (en) Pharmaceutical composition for preventing and treating menstrual disease and preparation method and application of composition
CN102210820A (en) Chinese medicinal composition for treating leukemia
CN101011544A (en) Gout rapid recovery pill(capsule) and preparation technique thereof
CN101843694B (en) Chinese medicament for treating chronic hepatitis
CN101972386A (en) Traditional Chinese medicine for treating diabetic gout
CN102133271B (en) Medicinal tea for curing gout
CN102078527A (en) Traditional Chinese medicine formula for treating urinary calculus
CN102091188A (en) Traditional Chinese medicine for treating diabetic kidney diseases
CN101530515B (en) Traditional Chinese medicine for treating diabetes mellitus complicated by intumescent prostate
CN100998722A (en) Oral traditional Chinese medicine for treating delayed menstrual ciycle menalgia
CN101940674A (en) Chinese medicament for treating diabetic peripheral neuropathy
CN102389473A (en) Traditional Chinese medicine used for treating diabetic constipation
CN101961386A (en) Traditional Chinese medicine for treating diabetic skin pruritus
CN102139049A (en) Traditional Chinese medicine for treating diabetic skin pruritus
CN102138969A (en) Traditional Chinese medicine for treating diabetic diarrhea
CN102048831A (en) Traditional Chinese medicine for treating cirrhosis
CN102114074A (en) Traditional Chinese medicine for treating diabetic diarrhea

Legal Events

Date Code Title Description
PB01 Publication
C06 Publication
SE01 Entry into force of request for substantive examination
C10 Entry into substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110706

C02 Deemed withdrawal of patent application after publication (patent law 2001)